Age, Biography and Wiki
Philip Leder was born on 19 November, 1934 in Washington, D.C., is an American geneticist (1934–2020). Discover Philip Leder's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 85 years old?
| Popular As |
N/A |
| Occupation |
N/A |
| Age |
85 years old |
| Zodiac Sign |
Scorpio |
| Born |
19 November 1934 |
| Birthday |
19 November |
| Birthplace |
Washington, D.C. |
| Date of death |
2 February, 2020 |
| Died Place |
Chestnut Hill, Massachusetts, U.S. |
| Nationality |
United States
|
We recommend you to check the complete list of Famous People born on 19 November.
He is a member of famous with the age 85 years old group.
Philip Leder Height, Weight & Measurements
At 85 years old, Philip Leder height not available right now. We will update Philip Leder's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Philip Leder Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Philip Leder worth at the age of 85 years old? Philip Leder’s income source is mostly from being a successful . He is from United States. We have estimated Philip Leder's net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
|
Philip Leder Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
Philip Leder (November 19, 1934 – February 2, 2020) was an American geneticist.
Leder was born in Washington, D.C., and studied at Harvard University, graduating in 1956.
In 1960, he graduated from Harvard Medical School and completed his medical residency at the University of Minnesota.
Leder made several contributions in each decade of the modern genetics era from the 1960s through the 1990s.
He may be best known for his early work with Marshall Nirenberg in the elucidation of the genetic code and the Nirenberg and Leder experiment.
Since then, he has made several contributions in the fields of molecular genetics, immunology and the genetics of cancer.
His group defined the base sequence of a complete mammalian gene (the gene for beta globin), which enabled him to determine its organization in detail, including its associated control signals.
His research into the structure of genes which carry the code for antibody molecules was of major significance.
The main focus of this inquiry was the question of how the vast diversity of antibody molecules is formed by a limited number of encoded genes.
Leder's work on antibody genes was later extended to research into Burkitt's lymphoma, a tumour of antibody-producing cells, which involves the oncogene c-myc.
This was crucial in understanding the origin of this type of tumor.
In 1968, Leder headed the Biochemistry Department of the Graduate Program of the Foundation for Advanced Education in the Sciences at the National Institute of Health.
In 1972 he was appointed director of the Laboratory for Molecular Genetics at the same institution and remained in that post until 1980, when he returned to Harvard Medical School as the founder of the newly formed Department of Genetics, occupying the John Emory Andrus Chair.
His many prizes include the Golden Plate Award of the American Academy of Achievement (1981), the Lasker Award (1987), the National Medal of Science (1991), the Harvey Prize, and the Heineken Prize awarded by the Royal Netherlands Academy of Arts and Sciences.
In 1988, Leder and Timothy Stewart were granted the first patent on a genetically engineered animal.
This animal, a mouse which had genes injected into its embryo to increase susceptibility to cancer, became known as the "oncomouse" and has been used in the laboratory study of cancer therapies.
In November 2015 he has been awarded an honorary doctoral degree from the Medical Faculty of the University of Basel for his lifetime achievements.
He retired from this position in 2008 and died of complications from Parkinson's disease on February 2, 2020.
Leder has been awarded various honors and was a member of the National Academy of Sciences, the American Academy of Arts and Sciences and the Institute of Medicine.
